Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Johannes G. Meran"'
Autor:
Enriqueta Felip, Josep Tabernero, Maria De Santis, Emile Voest, Mark Robson, Fatima Cardoso, Elisabeth G E de Vries, Fedro Alessandro Peccatori, Svetlana Jezdic, Giannis Mountzios, Smita Bhatia, Alexandru Eniu, Luzia Travado, Ulrich Keilholz, Jonas Bergh, Jan Buckner, Friedrich Stiefel, Ahmad Awada, Cristiana Sessa, Olivier Michielin, Marc Ernstoff, Ben Markman, Lisa Licitra, Rossana Berardi, Jill Gilbert, Lidia Schapira, Eva Schernhammer, Jeffrey S Weber, Heinz-Josef Lenz, Piotr Rutkowski, Jennifer Duff, Axel Grothey, Yuichiro Ohe, Saskia Litiere, Hans Wildiers, Christian Dittrich, Michael Kosty, Doug Pyle, Nagi El-Saghir, Jean-Pierre Lotz, Pia Österlund, Nicholas Pavlidis, Gunta Purkalne, Susana Banerjee, Jan Bogaerts, Paolo Casali, Edward Chu, Julia Lee Close, Bertrand Coiffier, Roisin Connolly, Sarah Coupland, Luigi De Petris, Don S Dizon, Linda R Duska, Martin F Fey, Nicolas Girard, Andor W J M Glaudemans, Priya K Gopalan, Stephen M Hahn, Diana Hanna, Christian Herold, Jørn Herrstedt, Krisztian Homicsko, Dennie V Jones, Lorenz Jost, Saad Khan, Alexander Kiss, Claus-Henning Köhne, Rainer Kunstfeld, Stuart Lichtman, Thomas Lion, Lifang Liu, Patrick J Loehrer, Merry Jennifer Markham, Marius Mayerhoefer, Johannes G Meran, Elizabeth Charlotte Moser, Timothy Moynihan, Torsten Nielsen, Kjell Öberg, Antonio Palumbo, Michael Pfeilstöcker, Chandrajit Raut, Scot C Remick, Roberto Salgado, Martin Schlumberger, Hans-Joachim Schmoll, Lowell Schnipper, Charles L Shapiro, Julie Steele, Cora N Sternberg, Florian Strasser, Roger Stupp, Richard Sullivan, Marcel Verheij, Everett Vokes, Jamie Von Roenn, Yosef Yarden
Publikováno v:
ESMO Open, Vol 1, Iss 5 (2016)
The European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO) are publishing a new edition of the ESMO/ASCO Global Curriculum (GC) thanks to contribution of 64 ESMO-appointed and 32 ASCO-appointed authors. Firs
Externí odkaz:
https://doaj.org/article/03442ec458e245ef83ebe8453a3f265c
Autor:
Josef Thaler, Marlies Moshammer, Johannes G. Meran, Gudrun Piringer, Wolfgang Eisterer, Birgit Grünberger, Leopold Öhler, Laurenz Vormittag, Johannes Andel, Vera Trommet
Publikováno v:
Wiener klinische Wochenschrift. 132(15-16)
A frequent side effect of the multikinase inhibitor regorafenib is fatigue. Physical activity has shown potential in reducing cancer-related fatigue. This non-interventional pilot study assessed physical activity levels of metastatic colorectal cance
Autor:
Claudia Bozzaro, Christoph Gabl, Ulrich H. J. Körtner, Thomas Daniczek, Aurelia Miksovsky, Thomas Wienerroither, Rudolf Likar, Maria Kletecka-Pulker, Hilde Kössler, Johannes G. Meran, Angelika Feichtner, Herbert H. Watzke, Bernhard Hammerl-Ferrari, Bettina Pusswald, Dietmar Weixler, Sophie Roider-Schur
Publikováno v:
Wiener Medizinische Wochenschrift. 167:31-48
Die Palliative Sedierungstherapie (PST) ist eine wichtige und ethisch akzeptierte Therapie in der Versorgung von ausgewahlten sterbenden Menschen, welche aufgrund therapierefraktarer Symptome fur sie unertragliches Leiden erleben. PST findet zunehmen
Autor:
Martin Schostak, Ulrike Schumacher, Uwe Zimmermann, Marc Schmitz, Marc-Oliver Grimm, Friedemann Zengerling, Barbara Grün, Wolfgang Loidl, Bernd J. Schmitz-Dräger, Susan Foller, Johannes G. Meran, Gustavo B. Baretton
Publikováno v:
Journal of Clinical Oncology. 39:446-446
446 Background: Several PD-1 immune-checkpoint inhibitors including Nivolumab (Nivo) are approved in urothelial cancer. Recently, in the front line setting, improved activity of combined PD-L1 and CTLA4 immune-checkpoint inhibition has been reported
Publikováno v:
Wiener Medizinische Wochenschrift. 169:355-355
Publikováno v:
Wiener Medizinische Wochenschrift. 169:305-306
Autor:
Dietmar Weixler, Herbert H. Watzke, Manuela Schmidinger, Eva Katharina Masel, Johannes G. Meran, Doris Posch, Sophie Schur
Publikováno v:
Wiener klinische Wochenschrift. 127:635-638
Personalized cancer treatment utilizing targeted therapies in a tailored approach is based on tumor and/or patient-specific molecular profiles. Recent clinical trials continue to look for new potential targets in heavily pretreated patients or rare d
Publikováno v:
Wiener Medizinische Wochenschrift. 164:499-502
Autor:
Stefan Kudlacek, Nicole Kraischits, Paul Schramek, Michael Lamche, Thomas Kunit, Dora Niedersüss-Beke, Reinhard Böhm, Wolfgang Loidl, Thomas Puntus, Johannes G. Meran, Birgit Grünberger
Publikováno v:
Oncology. 93(1)
Background: Neoadjuvant chemotherapy with methotrexate-vinblastine-doxorubicin-cisplatin (MVAC) is the standard of care for muscle-invasive urothelial bladder cancer. Gemcitabine plus cisplatin (GC) shows similar efficacy with less toxicity in the me
Autor:
Dietmar, Weixler, Sophie, Roider-Schur, Rudolf, Likar, Claudia, Bozzaro, Thomas, Daniczek, Angelika, Feichtner, Christoph, Gabl, Bernhard, Hammerl-Ferrari, Maria, Kletecka-Pulker, Ulrich H J, Körtner, Hilde, Kössler, Johannes G, Meran, Aurelia, Miksovsky, Bettina, Pusswald, Thomas, Wienerroither, Herbert, Watzke
Publikováno v:
Wiener medizinische Wochenschrift (1946). 167(1-2)
Palliative sedation therapy (PST) is an important and ethically accepted therapy in the care of selected palliative care patients with otherwise unbearable suffering from refractory distress. PST is increasingly used in end-of-life care. Austria does